Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTS Alpha Tau Medical	$2.98 -1.3%	$2.89	$1.93 ▼ $4.39	$252.76M	0.99	49,088 shs	52,082 shs
ECOR electroCore	$5.45 +0.9%	$5.66	$4.47 ▼ $19.49	$40.44M	0.79	98,996 shs	32,650 shs
ELMD Electromed	$21.99 +1.5%	$21.32	$13.74 ▼ $35.56	$184.41M	0.4	78,525 shs	1.01 million shs
INGN Inogen	$7.08 -1.7%	$6.63	$5.70 ▼ $13.33	$190.38M	1.65	243,107 shs	358,961 shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTS Alpha Tau Medical	0.00%	+2.76%	+0.68%	+18.73%	+17.79%
ECOR electroCore	0.00%	+6.24%	+7.28%	-18.54%	-15.24%
ELMD Electromed	0.00%	+7.11%	+8.86%	-7.84%	+46.31%
INGN Inogen	0.00%	+6.63%	+9.94%	-0.70%	-12.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DRTS Alpha Tau Medical	2.5233 of 5 stars	3.5	3.0	0.0	3.0	1.7	0.0
ECOR electroCore	2.7592 of 5 stars	3.5	3.0	0.0	1.6	2.5	0.6
ELMD Electromed	1.2082 of 5 stars	2.0	5.0	0.0	0.6	1.7	0.0
INGN Inogen	4.2616 of 5 stars	3.3	4.0	3.9	1.4	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRTS Alpha Tau Medical	3.00	Buy	$8.00	168.46% Upside
ECOR electroCore	3.00	Buy	$25.50	367.89% Upside
ELMD Electromed	4.00	Strong Buy	$38.00	72.81% Upside
INGN Inogen	2.50	Moderate Buy	$11.00	55.37% Upside

Current Analyst Ratings Breakdown

Latest ECOR, ELMD, INGN, and DRTS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
5/22/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy	$12.00
5/15/2025	ELMD Electromed	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/8/2025	INGN Inogen	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$10.00 ➝ $7.00
4/29/2025	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$9.00 ➝ $9.00
4/9/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.89 per share	N/A
ECOR electroCore	$25.18M	1.61	N/A	N/A	$1.13 per share	4.82
ELMD Electromed	$61.44M	3.00	$0.53 per share	41.36	$5.10 per share	4.31
INGN Inogen	$335.70M	0.57	N/A	N/A	$7.30 per share	0.97

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRTS Alpha Tau Medical	-$31.75M	-$0.46	N/A	N/A	N/A	N/A	-49.48%	-36.69%	8/13/2025 (Estimated)
ECOR electroCore	-$11.89M	-$1.56	N/A	N/A	N/A	-46.24%	-149.04%	-61.24%	8/6/2025 (Estimated)
ELMD Electromed	$5.15M	$0.79	29.32	∞	N/A	11.34%	15.71%	13.37%	N/A
INGN Inogen	-$35.89M	-$1.15	N/A	N/A	N/A	-8.08%	-14.76%	-9.01%	8/5/2025 (Estimated)

Latest ECOR, ELMD, INGN, and DRTS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/19/2025	Q1 2025	DRTS Alpha Tau Medical	-$0.14	-$0.12	+$0.02	-$0.12	$0.03 million	N/A
5/7/2025	Q1 2025	ECOR electroCore	-$0.56	-$0.47	+$0.09	-$0.47	$6.93 million	$6.72 million
5/7/2025	Q1 2025	INGN Inogen	-$0.52	-$0.25	+$0.27	-$0.25	$79.57 million	$82.28 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRTS Alpha Tau Medical	0.10	5.81	5.81
ECOR electroCore	N/A	1.52	1.30
ELMD Electromed	N/A	5.10	4.74
INGN Inogen	N/A	3.07	2.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DRTS Alpha Tau Medical	2.65%
ECOR electroCore	26.74%
ELMD Electromed	40.82%
INGN Inogen	89.94%

Insider Ownership

Company	Insider Ownership
DRTS Alpha Tau Medical	39.50%
ECOR electroCore	19.70%
ELMD Electromed	14.00%
INGN Inogen	1.46%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DRTS Alpha Tau Medical	80	84.82 million	51.32 million	No Data
ECOR electroCore	50	7.42 million	5.96 million	Not Optionable
ELMD Electromed	160	8.39 million	7.36 million	Optionable
INGN Inogen	1,030	26.89 million	26.49 million	Optionable

ECOR, ELMD, INGN, and DRTS Headlines

Recent News About These Companies

Inogen-Yuwell launch new stationary oxygen concentrator

June 24, 2025 | hmenews.comH

Inogen-Yuwell launch new stationary oxygen concentrator

June 24, 2025 | hmenews.comH

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

June 23, 2025 | businesswire.com

What is B. Riley's Forecast for Inogen Q2 Earnings?

June 18, 2025 | marketbeat.com

Inogen (NASDAQ:INGN) Upgraded by B. Riley to "Strong-Buy" Rating

June 17, 2025 | marketbeat.com

Inogen (INGN) Stock Coverage Initiated by B. Riley Securities | INGN Stock News

June 16, 2025 | gurufocus.com

Inogen: Still Breathing, But Margin Pressures Persist

June 16, 2025 | seekingalpha.com

Inogen (NASDAQ:INGN) Coverage Initiated by Analysts at B. Riley

June 16, 2025 | marketbeat.com

Inogen (INGN) Initiated with Buy Rating by B. Riley Analyst | INGN Stock News

June 16, 2025 | gurufocus.com

Inogen (INGN) Receives Buy Rating and $14 Target from B. Riley | INGN Stock News

June 15, 2025 | gurufocus.com

Here’s Why Brown Capital Management Small Company Fund Sold Inogen (INGN) in Q1

June 10, 2025 | insidermonkey.com

Two Sigma Advisers LP Lowers Holdings in Inogen, Inc. (NASDAQ:INGN)

June 8, 2025 | marketbeat.com

Inogen (INGN) Down 0.8% Since Last Earnings Report: Can It Rebound?

June 7, 2025 | msn.com

46,224 Shares in Inogen, Inc. (NASDAQ:INGN) Purchased by Squarepoint Ops LLC

June 5, 2025 | marketbeat.com

Millennium Management LLC Acquires 88,924 Shares of Inogen, Inc. (NASDAQ:INGN)

June 5, 2025 | marketbeat.com

With 72% ownership of the shares, Inogen, Inc. (NASDAQ:INGN) is heavily dominated by institutional owners

May 30, 2025 | finance.yahoo.com

Here's Why You Should Add Inogen Stock to Your Portfolio Now

May 28, 2025 | zacks.com

Zacks.com featured highlights Urban Outfitters, Inogen and Southwest Gas

May 28, 2025 | finance.yahoo.com

3 Stocks With Upgraded Broker Ratings to Bet on Amid Uncertainties

May 27, 2025 | zacks.com

Inogen shares upgraded to Buy at Needham, $12 price target set

May 24, 2025 | uk.investing.com

Needham Upgrades Inogen (INGN) to Buy

May 23, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending
Broadcom Earnings Preview: AVGO Stock Near Record Highs
By Leo Miller | June 3, 2025
View Broadcom Earnings Preview: AVGO Stock Near Record Highs

ECOR, ELMD, INGN, and DRTS Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

$2.98 -0.04 (-1.32%)

Closing price 06/27/2025 03:55 PM Eastern

Extended Trading

$3.09 +0.11 (+3.66%)

As of 04:13 AM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

electroCore NASDAQ:ECOR

$5.45 +0.05 (+0.93%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$9.80 +4.35 (+79.82%)

As of 04:00 AM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Electromed NYSE:ELMD

$21.99 +0.32 (+1.48%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$22.94 +0.95 (+4.32%)

As of 04:00 AM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Inogen NASDAQ:INGN

$7.08 -0.12 (-1.67%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$7.18 +0.10 (+1.41%)

As of 04:00 AM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time